Chosa Oncology Investor Relations Material
Latest events
Investor Update
Chosa Oncology
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Chosa Oncology
Access all reports
Chosa Oncology AB is a Sweden-based biotechnology company focused on the development of innovative cancer therapies. The company specializes in identifying and advancing novel treatment options targeting unmet medical needs in oncology. The company is headquartered in Stockholm, Sweden, and its shares are listed on the Spotlight Stock Market.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
CHOSA
Country
🇸🇪 Sweden